Filaggrin loss-of-function variants are associated with atopic dermatitis phenotypes in a diverse, early-life prospective cohort
JCI Insight · 08.05.2024 · 9 (9)
DOI: 10.1172/jci.insight.178258 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 02.04.2024. Verfasst von Samuel J Virolainen und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Genetics and. Hauptthemen laut MEDLINE: Filaggrin Proteins, Dermatitis, Atopic, Loss of Function Mutation, Phenotype. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NINDS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Loss-of-function (LoF) variants in the filaggrin ( FLG ) gene are the strongest known genetic risk factor for atopic dermatitis (AD), but the impact of these variants on AD outcomes is poorly understood. We comprehensively identified genetic variants through targeted region sequencing of FLG in children participating in the Mechanisms of Progression of Atopic Dermatitis to Asthma in Children cohort. Twenty FLG LoF variants were identified, including 1 novel variant and 9 variants not previously associated with AD. FLG LoF variants were found in the cohort. Among these children, the presence of 1 or more FLG LoF variants was associated with moderate/severe AD compared with those with mild AD. Children with FLG LoF variants had a higher SCORing for Atopic Dermatitis (SCORAD) and higher likelihood of food allergy within the first 2.5 years of life. LoF variants were associated with higher transepidermal water loss (TEWL) in both lesional and nonlesional skin. Collectively, our study identifies established and potentially novel AD-associated FLG LoF variants and associates FLG LoF variants with higher TEWL in lesional and nonlesional skin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Human Genetics and.
- Center for Autoimmune Genomics and Etiology, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
- Immunology Graduate Program and.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Division of Asthma Research, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
- Pacific Biosciences, Menlo Park, California, USA.
Förderung
- NIAID NIH HHS
- NINDS NIH HHS
- NIDDK NIH HHS
- NHGRI NIH HHS
- NIGMS NIH HHS
- NIAMS NIH HHS
- National Institutes of Health
Zitieren
APA
Virolainen, S. J., Satish, L., Biagini, J. M., Chaib, H., Chang, W. C., Dexheimer, P. J., Dixon, M. R., Dunn, K., Fletcher, D., Forney, C., Granitto, M., Hestand, M. S., Hurd, M., Kauffman, K., Lawson, L., Martin, L. J., Peña, L. D., Phelan, K. J., Shook, M., …, & Kottyan, L. C. (2024). Filaggrin loss-of-function variants are associated with atopic dermatitis phenotypes in a diverse, early-life prospective cohort. JCI Insight, 9(9). https://doi.org/10.1172/jci.insight.178258
Vancouver
Virolainen SJ, Satish L, Biagini JM, Chaib H, Chang WC, Dexheimer PJ, et al. Filaggrin loss-of-function variants are associated with atopic dermatitis phenotypes in a diverse, early-life prospective cohort. JCI Insight. 2024;9(9). doi:10.1172/jci.insight.178258
BibTeX
@article{Virolainen2024,
author = {Virolainen, Samuel J and Satish, Latha and Biagini, Jocelyn M and Chaib, Hassan and Chang, Wan Chi and Dexheimer, Phillip J and Dixon, Michael R and Dunn, Katelyn and Fletcher, David and Forney, Carmy and Granitto, Marissa and Hestand, Matthew S and Hurd, Makenna and Kauffman, Kenneth and Lawson, Lucinda and Martin, Lisa J and Peña, Loren Dm and Phelan, Kieran J and Shook, Molly and Weirauch, Matthew T and Khurana Hershey, Gurjit K and Kottyan, Leah C},
title = {Filaggrin loss-of-function variants are associated with atopic dermatitis phenotypes in a diverse, early-life prospective cohort},
journal = {JCI Insight},
year = {2024},
volume = {9},
number = {9},
doi = {10.1172/jci.insight.178258}
}
EUVIMED